Issuu on Google+

Life Sciences Startups Entrepreneurship Course Monday 10 September

8:30 ‐ 9:00 Registration / Coffee 9:00 ‐ 9:15 Welcome Remarks by Organizer “Versli Lietuva” Speakers: Paulius Lukauskas, Director, Lithuanian Enterprise

9:15 - 9:45 Opening Remarks by Co‐Chairs and Participants Introduction Moderators: Remis Bistras (Boston, USA), Ruta Laukien (Boston, USA)

9:45 ‐ 10:15 Session 1: Life Science Start-ups: Industry Landscape, Challenges and Opportunities - Long pathway toward a successful exit Overview of the challenges and opportunities for life science startups. This session will also provide tools and a contextual framework as to how technologies can be assessed for capitalization and partnering, outlines ways for exit. Speakers: Remis Bistras, Ruta Laukien

10:15 - 10:30 Break 10:30 ‐ 11:30 Session 2. Business Case. PureTech Ventures in 2011 – Strategies for financing. Break‐out Sessions and Business Case discussion in small groups. Group report outs and recommendations Moderators: Remis Bistras, Ruta Laukien

11:30 – 12:15 Session 3: Forming company; Accelerating Developing; Virtual companies, Incubators Speaker: Gary Keller (CEO Xomix, Chicago, USA)

12:15 – 13:15 Lunch 13:15 – 14:00 Session 4: What do you really own? What Every Investigator Must Know about IP, Patents In-licensing and IP Management in Life Science Startups The goal of the session is to provide information and insight into the specific issues confronting investigators, entrepreneurs, investors and their patent attorneys. Additionally, we will discuss the prevailing treatment by the European and USA PTOs and the courts of specific issues and implications, international issues, filling etc. Speaker: Liudas Karnickas, IP Attorney, Senior Associate at LAWIN, Vilnius, Lithuania

14:00 – 14:20 Forming company for success and investment. Speaker: Andrius Iskauskas, Attorney, AAA Baltic Service Company, Vilnius, Lithuania

Course prepared by Walden Vision in cooperation with Remis Bistras and Ruta Laukien


14:20 – 14:35 Break 14:35 - 15:20 Session 6: Seeking and Finding Investment for your Venture: Investors Perspective Raising capital – one step at a time. Seed money, Angel Investors, Venture Capital and other professional investors, Strategic Investors (pharma companies) “Packaging” the company in order to seek the outside investment, preparing an investors pitch, valuation, approaching investors and negotiating a deal. Considerations and pitfalls on the investment process. The session provides a framework for developing a pitch and the key points and milestones of a business plan. Lecturer/Moderator: Ruta Laukien

15:20 – 15:30 Break 15:30 – 16:15 Session 5: Licensing Intellectual Property; Working with Universities and Successful Technology Transfer process Lecturer: Dr. Rathindra Bose, Vice President for Research and Professor of Chemistry at The University of Houston, USA

16:15 – 16:55 Session 7: Licensing, Partnering, Strategic Alliances, M&A – Strategic Partners perspective The session will overview Business Development , Licensing and partnering process and discuss expectations from potential partners: big pharma and biotech. Valuation of the product, preparing and strategic assessment of the company for a licensing/M&A campaign. Lecturer/Moderator: Remis Bistras

16:55 – 17:00 Wrap –up remarks 17:00 – 18:00 Reception and Networking

Course prepared by Walden Vision in cooperation with Remis Bistras and Ruta Laukien


Tuesday 11 September

8:30 – 9:00 Registration, Refreshments 9:00 – 10:00 Key note address:. Fermentas: A pathway to success. Speaker: Dr. Makauskas , CEO Fermentas/Thermo Fisher

10:00 – 10:15 Break 10:15 ‐ 12:15 Participating Start-up Companies Deliver an Investment Pitch A start-up will present an investment pitch for his/her company to a panel of life science industry professionals who will make a real‐time critique and recommendations. Course participants will be invited to share their own views as well. Format: Company pitch (5-7 minutes) ; Q&A; Panel feedback, discussion + audience feedback. Total 15 minutes

12:15 – 1:15

Lunch

13:15 - 14:00 Product Development and Regulatory Planning and the Implications for Strategy and Financing This session provides the specific insight into planning for regulatory approval and regulations in light of strategy, financial needs, and the concerns of prospective partners and investors. Speaker : John Mowles, UK

14:00 – 14:15 Break 14:15 – 16:30 Participating Start-up Companies deliver an investment pitch A start-up will present a partnering pitch for his/her company to a panel of life science industry professionals who will make a real‐time critique and recommendations. Course participants will be invited to share their own views as well. Format: Company pitch (5-7 minutes) ; Q&A; Panel feedback, discussion + audience feedback. Total per company: 15 minutes

16:30 - 17:00 Wrap –up, Closing Remarks, Adjournment

Course prepared by Walden Vision in cooperation with Remis Bistras and Ruta Laukien


Life Sciences Startups Entrepreneurship Course